Can you explain this chapter from swarts Chapter: 26 - Stomach Robert E. Roses and Daniel T. Dempsey Neet ga explain chei also i will give you the case relate this chapter to that case A 65-yo male was a diagnosed of case of chronic gouty arthritis. He was advised to take Ibuprofen as a remedy if ever he experiences an attack. Because of financial constraints, he was unable to follow up with his rheumatologist regarding his gout and will usually double or triple the dose of Ibuprofen if the pain becomes severe or difficult to handle. Recently, the patient encountered recurrent gouty flares and has been taking his medication almost daily with double or triple the dose. The patient was eating his dinner with his family when he suddenly experienced epigastric discomfort. He initially tolerated it and drank 2 glasses of water to relieve the pain. The pain was described to be stabbing and steady in character. Around 2 hours after, the patient noted an increase in the severity of pain, noted to be pale and diaphoretic and was screaming in pain. He was brought to a DMSF Hospital where you are the clinical clerk on duty.   1. Extract additional information regarding patient’s history. 2. Perform the necessary assessment needed to diagnose the disease. 3. Give your initial impression on the case. 4. Correlate the symptoms with the patient’s risk factors to develop the disease considered. 5. Provide the necessary diagnostic modalities necessary to confirm or reject your initial impression. 6. Enumerate your plans for the patient.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
I now have all the content needed from Schwartz's Chapter 26. Let me write the comprehensive case-integrated answer.

Schwartz's Chapter 26 - Stomach: Explained & Applied to the Case

Authors: Robert E. Roses and Daniel T. Dempsey

Chapter Overview

Chapter 26 of Schwartz's Principles of Surgery covers the stomach comprehensively - from anatomy and physiology to the full spectrum of gastric diseases. The key topics are: anatomy, acid physiology, gastric mucosal barrier, peptic ulcer disease (PUD), its complications (bleeding, perforation, obstruction), surgical treatment, and gastric neoplasms. This case centers on PUD complicated by perforation, so the most relevant sections are those on NSAID-mediated injury, pathophysiology of ulceration, and perforated peptic ulcer.

PART 1: Key Chapter Concepts

Anatomy

The stomach is divided into the cardia, fundus, body (corpus), antrum, and pylorus. The lesser curvature is supplied by the left and right gastric arteries; the greater curvature by the left and right gastroepiploic arteries. The short gastric arteries supply the fundus. Venous drainage parallels the arterial supply and ultimately drains into the portal system.

Gastric Acid Physiology

Acid is secreted by parietal cells (oxyntic cells) located in the body and fundus. Stimulation occurs via three pathways:
  • Neural: Vagal stimulation via acetylcholine
  • Hormonal: Gastrin from antral G-cells
  • Paracrine: Histamine from ECL cells (the dominant pathway for gastrin)
Basal Acid Output (BAO) is normally 2-3 mEq/hr; Maximal Acid Output (MAO) following stimulation is ~20-30 mEq/hr.

Gastric Mucosal Barrier - "Why We Don't Digest Ourselves"

This is the most critical concept for understanding this case.
Balance of Aggressive vs Defensive Factors in the Gastric Mucosa (Schwartz's Fig. 26-27)
As shown above, peptic ulcer ultimately results from an imbalance between aggressive and defensive forces:
AggressiveDefensiveRepair
AcidBicarbonate secretionRestitution
PepsinBlood flowMucoid cap
NSAIDsMucus layerProliferation
H. pyloriCell junctions / Apical resistanceGrowth factors
The mucosal defense components include:
  • Mucous barrier (traps bicarbonate close to epithelium)
  • Bicarbonate secretion (maintains a near-neutral pH at the cell surface)
  • Epithelial barrier with tight junctions
  • Hydrophobic phospholipids
  • Rapid restitution of injured cells
  • Microcirculation (reactive hyperemia)
  • Prostaglandins - THE KEY MEDIATOR affected by NSAIDs
(Schwartz's Principles of Surgery, 11th ed., p. 1109)

NSAIDs and Peptic Ulcer Disease - The Core Mechanism

"Chronic use of NSAIDs (including aspirin) increases the risk of peptic ulcer disease about fivefold and upper GI bleeding at least twofold." - Schwartz's, p. 1121
NSAIDs cause GI injury through two mechanisms:
  1. Topical/direct injury - Weak acids that become ion-trapped in gastric epithelial cells, causing direct cellular damage
  2. Systemic COX-1 inhibition - NSAIDs inhibit cyclooxygenase-1 (COX-1), the constitutive isoform responsible for producing prostaglandins (PGE2, PGI2) in the gastric mucosa. These prostaglandins:
    • Stimulate mucus and bicarbonate secretion
    • Maintain mucosal blood flow
    • Inhibit acid secretion
    • Promote epithelial restitution
When COX-1 is blocked by NSAIDs → prostaglandin production falls → mucus and bicarbonate secretion decrease → mucosal blood flow decreases → the barrier fails → acid penetrates → ulceration.
Risk factors for NSAID-induced GI complications (from Schwartz's, p. 1121):
  • Age >60
  • Prior GI event
  • High NSAID dose (directly relevant here)
  • Concurrent steroid intake
  • Concurrent anticoagulant intake
The risk in elderly patients on NSAIDs is 10 times that of controls for requiring an operation from a GI complication, and 4.5 times higher for death from a GI cause. (Schwartz's, p. 1121)

Peptic Ulcer Disease - Pathophysiology

PUD involves focal defects in gastric or duodenal mucosa that extend into the submucosa or deeper. The two dominant causes are:
  1. H. pylori infection
  2. NSAID/aspirin use
Type V gastric ulcers (by the modified Johnson classification) are medication-induced and can occur anywhere in the stomach.
Complications of PUD (in decreasing frequency):
  1. Bleeding (most common, most deaths)
  2. Perforation (second most common; now more common indication for surgery)
  3. Obstruction
"As with bleeding ulcer, NSAID and/or aspirin use have been inextricably linked with perforated PUD, especially in the elderly population." (Schwartz's, p. 1134)

Perforated Peptic Ulcer - Schwartz's Full Coverage

Perforation occurs when an ulcer erodes through the entire wall of the stomach or duodenum, releasing gastric contents into the peritoneal cavity. This causes chemical peritonitis initially (sterile, from acid and enzymes), which within hours becomes bacterial peritonitis.
Clinical features:
  • Sudden onset of severe, steady, knife-like epigastric pain (this is the classic description)
  • Rapid progression to diffuse abdominal pain
  • Board-like rigidity of the abdomen (guarding/rigidity)
  • Referred pain to the shoulder (diaphragmatic irritation)
  • Signs of peritonitis: tenderness, rebound, guarding
  • As time passes: pallor, diaphoresis, tachycardia, hypotension (shock)
  • Free air under the diaphragm on imaging
Surgery is almost always indicated. Nonsurgical management is reserved for the stable patient without peritonitis in whom a sealed perforation is radiologically confirmed.

PART 2: Case Application

Clinical Recap

65-year-old male with chronic gouty arthritis, on Ibuprofen (an NSAID) self-medicating with double or triple doses almost daily for recurrent flares. Presents with sudden-onset epigastric stabbing and steady pain that worsened over 2 hours, with pallor and diaphoresis, screaming in pain.

Question 1: Additional History to Extract

As clinical clerk, you need to gather:
Pain History (OLDCARTS):
  • Onset: Was it truly sudden ("like a knife") or gradual?
  • Prior episodes of epigastric pain, heartburn, or dyspepsia?
  • Any hematemesis (vomiting blood) or melena (black tarry stools)?
  • Does anything relieve the pain (food, antacids)?
NSAID Intake Details:
  • Exact dose and frequency (how many tabs per episode)
  • Duration of regular daily use
  • Any concomitant alcohol use
  • Any prior GI events (bleeding, hospitalization)
Medical/Surgical History:
  • Any prior GI endoscopy? Prior PUD diagnosis?
  • Any other medications (steroids, anticoagulants, aspirin)?
  • Smoking history (independent risk factor for PUD)
  • Comorbidities: hypertension, diabetes, cardiovascular disease
Family History: GI cancers, peptic ulcer disease
Review of Systems:
  • Weight loss, anorexia (rule out malignancy)
  • Urinary symptoms
  • Fever/chills
  • Any referred shoulder pain (diaphragm irritation from free air)

Question 2: Necessary Assessment

Vital Signs (PRIORITY):
  • Blood pressure, heart rate, respiratory rate, temperature, O2 saturation
  • The pallor and diaphoresis suggest hemodynamic instability - assess for shock (hypotension + tachycardia)
Physical Examination:
AreaExpected Finding
GeneralIll-appearing, diaphoretic, pale, in acute distress
AbdomenBoard-like rigidity (involuntary guarding), diffuse tenderness with rebound, absent bowel sounds (ileus from peritonitis)
EpigastriumMaximum tenderness
Liver dullnessMay be absent on percussion (Traube's space) - indicates free air
Rectal examCheck for melena (blood in stool = concurrent bleed)
CardiovascularTachycardia, possibly hypotension

Question 3: Initial Impression

PERFORATED PEPTIC ULCER - most likely a perforated duodenal or prepyloric gastric ulcer (Type III Johnson) given:
  • Sudden onset of severe, stabbing, steady epigastric pain - the classic presentation of perforation
  • Rapid deterioration over 2 hours with signs of peritonitis (pallor, diaphoresis, screaming pain)
  • Strong predisposing etiology (chronic high-dose NSAID use)
Differential diagnoses to consider:
  1. Acute pancreatitis (epigastric pain, but usually radiates to back, more gradual)
  2. Acute myocardial infarction (can present as epigastric pain in elderly)
  3. Mesenteric ischemia (more diffuse, pain out of proportion to exam)
  4. Bleeding peptic ulcer without perforation
  5. Aortic aneurysm rupture

Question 4: Risk Factor Correlation

Risk FactorRelevance from Chapter 26
Age 65Age >60 increases NSAID GI complication risk 5x vs controls; risk of needing operation is 10x higher (Schwartz's p. 1121)
Chronic NSAID use (Ibuprofen)NSAIDs inhibit COX-1 → decrease prostaglandin synthesis → break down mucosal defense (mucus, bicarbonate, blood flow)
Double/triple dosingHigh NSAID dose is explicitly listed as a risk factor for GI complications (Schwartz's, p. 1121)
Daily useChronic, near-daily exposure without PPI prophylaxis - highest risk scenario
No PPI co-prescriptionPPIs or high-dose H2RAs should always accompany NSAIDs in high-risk patients; omission here likely contributed to ulceration
No regular follow-upMissed opportunity to detect and treat ulcer before perforation
Possible H. pylori co-infectionOlder males, especially in developing-country settings, have high H. pylori prevalence; co-infection with NSAID use dramatically amplifies risk
The mechanism is a failure of mucosal defense - Ibuprofen suppressed prostaglandin production, reducing mucus and bicarbonate secretion and compromising the mucosal blood flow. High doses overwhelmed any residual defense, leading to ulceration and ultimately full-thickness perforation.

Question 5: Diagnostic Modalities

Immediate/Bedside:
  • Erect Chest X-ray - Look for free air under the diaphragm (pneumoperitoneum) - present in ~70-80% of perforations. This is the single most important initial test.
  • ECG - Rule out NSTEMI/STEMI (epigastric presentation)
Laboratory:
TestPurpose
CBCLeukocytosis (infection/peritonitis); anemia (bleeding)
Serum amylase/lipaseRule out pancreatitis
Comprehensive metabolic panelBUN/Cr (elevated BUN/Cr ratio suggests upper GI bleed), electrolytes
Serum lactateAssess for sepsis/ischemia
ABGMetabolic acidosis if shocked
PT/INR, aPTTPre-operative coagulation status
Type and crossmatchPre-operative preparation
Blood culturesIf sepsis suspected
H. pylori serology or stool antigenTo guide post-operative eradication therapy
Imaging:
ModalityFinding
Erect CXRFree air under diaphragm (pneumoperitoneum)
CT Abdomen/Pelvis with IV contrastGold standard - identifies free air, free fluid, perforation site, extent of peritoneal contamination
Left lateral decubitus X-rayAlternative if erect CXR equivocal
Upright abdominal X-rayAdjunct
Note: Upper GI endoscopy is generally contraindicated in suspected perforation as insufflation worsens pneumoperitoneum.
Risk Stratification:
  • AIMS65 score for inhospital mortality and length of stay
  • Blatchford score and Rockall score if bleeding is also suspected (Schwartz's, p. 1131)

Question 6: Management Plans

IMMEDIATE - Resuscitation (ABCs):
  1. IV access - Two large-bore IVs
  2. Aggressive IV fluid resuscitation - Crystalloids; correct hypotension/shock
  3. NPO (nothing by mouth)
  4. Nasogastric tube (NGT) - Decompress stomach, reduce ongoing spillage
  5. Urinary catheter - Monitor urine output (target >0.5 mL/kg/hr)
  6. High-dose IV Proton Pump Inhibitor - e.g., Pantoprazole or Omeprazole IV
  7. IV Antibiotics - Broad-spectrum (e.g., Piperacillin-tazobactam or Cefazolin + Metronidazole) to cover GI flora
  8. Analgesia - IV opioids (morphine/tramadol) for pain control
  9. Surgical consultation - URGENT
DEFINITIVE - Surgical Management:
Per Schwartz's Fig. 26-44 (shown below):
Algorithm for Operation for Perforated Peptic Ulcer - Schwartz's Fig. 26-44
Given this patient is:
  • Elderly (65 yo) with likely hemodynamic instability
  • Presenting ~2 hours after onset with escalating symptoms
  • High operative risk
The likely procedure is simple patch closure (Graham patch/omentopexy) of the perforation:
  • Close perforation with omental patch
  • Lavage the peritoneal cavity thoroughly
  • Consider adding highly selective vagotomy (HSV) if patient is stable and has chronic ulcer history
For duodenal ulcer: patch + HSV or patch + truncal vagotomy and drainage For gastric ulcer: wedge resection or distal gastrectomy if stable
Post-operative Plans:
  1. Continue IV PPI; transition to oral PPI long-term
  2. Stop all NSAIDs - Switch gout management to colchicine or allopurinol (discuss with rheumatology)
  3. Test and treat for H. pylori (rapid urease test on intraoperative biopsy or post-op serology; treat with triple therapy if positive)
  4. ICU or monitored bed post-operatively
  5. Monitor for complications: anastomotic leak, wound infection, sepsis
  6. Nutritional support
  7. Consider lifelong PPI if H. pylori negative (since NSAID-associated ulcer and cannot guarantee complete NSAID cessation)
  8. Patient education on NSAID dangers and importance of follow-up

Summary Table: Case vs. Chapter 26 Correlation

Chapter ConceptCase Application
Mucosal defense (prostaglandins)Ibuprofen → COX-1 inhibition → prostaglandin deficiency → mucosal failure
Type V gastric ulcer (NSAID-induced)Most likely ulcer type in this patient
Risk factors for NSAID-GI complicationsAge 65, high dose, chronic daily use = highest risk tier
PUD complications: perforation (2nd most common)Sudden severe epigastric pain → chemical peritonitis → surgical emergency
Clinical signs of perforationStabbing steady pain, pallor, diaphoresis, rigidity
DiagnosisErect CXR (free air), CT abdomen, labs
Medical RxIV PPI, NGT, antibiotics, NPO, fluid resuscitation
Surgical RxGraham patch ± HSV; consider definitive ulcer operation if stable
Post-op RxPPI long-term, H. pylori test-and-treat, NSAID cessation

All clinical content referenced from Schwartz's Principles of Surgery, 11th Edition, Chapter 26 - Stomach (Robert E. Roses and Daniel T. Dempsey), pp. 1099-1154.
This is a shared conversation. Sign in to Orris to start your own chat.